IN-DATE
0655870: Bard X-Port Ti Low-Profile Implantable Port with 6F Attachable Open-Ended Polyurethane, Microintroducer
Photos are for illustration purposes only and may not depict the exact item.
Sign in to add this product to your favorites!
| Price: | $364.00 EACH |
|---|---|
| Quantity: | |
| In Stock: | 2 eaches |
| Expiration: | 02-2027 |
| Express: | Need it tomorrow? Order in next 3 hours 52 minutes and choose overnight shipping at checkout. |
Additional Details
X-Port™ Implantable Port
0655870
- Single Lumen
- Titanium
- Low Profile
- 6F Attachable Polyurethane
- Introducer: Peel-Apart
- Suture Option: Silicone-Filled
- Kit Configuration: Microintroducer
AccessGUDID Info
- FDA Product Code: LJT
- FDA Product Code Name: PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR
- GMDN Term Code: 61494
- GMDN Term Name: Vascular port/catheter
- GMDN Term Description: A fully-implantable device assembly intended to provide access to arteries/veins (excludes coronary and intracerebral circulation) for infusion (e.g., chemotherapeutic agents, blood transfusions) and/or drainage (e.g., blood). It consists of: 1) a subcutaneous chamber, with a self-sealing puncturable septum for percutaneous insertion of a hypodermic needle; and 2) an attached catheter which passes into the arteries/veins. It may consist of two chambers attached to a dual-lumen catheter for simultaneous infusion. It is made of metal [e.g., titanium (Ti)] and/or synthetic polymers (e.g., silicone); disposable devices associated with implantation may be included.
Manufacturer
C.R. Bard (a part of BD - Becton, Dickinson and Company) was a global leader in the development and manufacturing of innovative medical technologies. Known for their high-quality products, Bard specialized in solutions for vascular access, urology, oncology, and surgical specialties. Their product portfolio included catheters, biopsy devices, implantable ports, and hernia repair systems, designed to enhance patient care and procedural efficiency. As part of BD, the legacy of C.R. Bard continues to drive advancements in healthcare, delivering trusted solutions that improve outcomes for patients and providers worldwide.
